Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Acumen Pharmaceuticals Inc (ABOS)

Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 182,042
  • Shares Outstanding, K 60,080
  • Annual Sales, $ 0 K
  • Annual Income, $ -52,370 K
  • EBIT $ -77 M
  • EBITDA $ -80 M
  • 60-Month Beta 0.07
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.72

Options Overview Details

View History
  • Implied Volatility 243.52% ( +79.11%)
  • Historical Volatility 61.70%
  • IV Percentile 94%
  • IV Rank 71.45%
  • IV High 336.46% on 11/09/23
  • IV Low 10.88% on 10/11/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 202
  • Volume Avg (30-Day) 79
  • Put/Call OI Ratio 1.17
  • Today's Open Interest 3,009
  • Open Int (30-Day) 8,429

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.36
  • Number of Estimates 3
  • High Estimate -0.25
  • Low Estimate -0.46
  • Prior Year -0.24
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.21 +30.32%
on 10/10/24
3.14 -8.28%
on 10/30/24
+0.40 (+16.13%)
since 09/30/24
3-Month
2.15 +33.88%
on 09/06/24
3.49 -17.50%
on 07/31/24
-0.54 (-15.79%)
since 07/30/24
52-Week
1.81 +59.11%
on 11/10/23
5.09 -43.42%
on 03/04/24
+0.68 (+30.61%)
since 10/30/23

Most Recent Stories

More News
Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease Conference

ABOS : 2.88 (-4.95%)
Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

ABOS : 2.88 (-4.95%)
2 'Strong Buy'-Rated Stocks That Wall Street Believes Can Soar Over 360%

Analysts see enormous long-term potential in these two penny stocks.

ABOS : 2.88 (-4.95%)
ELDN : 4.65 (+10.98%)
$SPX : 5,705.45 (-1.86%)
2 Penny Stocks Wall Street Expects to Soar Over 400%

These two penny stock companies, while risky and volatile, have the potential to generate massive returns, according to Wall Street's price forecasts.

ABOS : 2.88 (-4.95%)
$SPX : 5,705.45 (-1.86%)
ELDN : 4.65 (+10.98%)
2 Penny Stocks That Wall Street Predicts Will Soar Over 300%

While these two penny stocks have the potential for exceptional returns, they also carry greater risk and volatility.

ELDN : 4.65 (+10.98%)
ABOS : 2.88 (-4.95%)
MRNA : 54.36 (-0.66%)
$SPX : 5,705.45 (-1.86%)
MarketBeat Week in Review – 7/17 - 7/21

Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks

U : 20.08 (-3.00%)
BTC : 6.21 (-2.51%)
MSFT : 406.35 (-6.05%)
META : 567.58 (-4.09%)
GOOGL : 171.11 (-1.92%)
NVDA : 132.76 (-4.72%)
RXRX : 6.32 (-5.39%)
OPK : 1.5100 (-0.66%)
PFE : 28.30 (-0.77%)
TSLA : 249.85 (-2.99%)
AAPL : 225.91 (-1.82%)
GP : 0.9800 (-2.97%)
Acumen Soars on Alzheimer's Study...Street Sees It Doubling

Will the $11.00 level be a double-top ceiling…or can Acumen Pharmaceuticals build momentum and climb towards its $25.00 IPO price?

ABOS : 2.88 (-4.95%)
LLY : 829.74 (-2.02%)
BIIB : 174.00 (-3.96%)
Why Shares of Acumen Pharmaceuticals Are Down Tuesday

The company announced a $100 million stock sale.

ABOS : 2.88 (-4.95%)
Stock Index Futures Muted Ahead of Key U.S. Retail Sales Data, U.S. Bank Earnings on Tap

September S&P 500 futures (ESU23) are down -0.03%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.10% this morning as market participants braced for the next round of quarterly reports while...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
TSLA : 249.85 (-2.99%)
AAPL : 225.91 (-1.82%)
ATVI : 94.42 (-0.05%)
MSFT : 406.35 (-6.05%)
F : 10.29 (-1.72%)
T : 22.54 (+2.36%)
BAC : 41.82 (-1.16%)
MS : 116.25 (-0.64%)
PLD : 112.94 (-2.53%)
LMT : 546.05 (+0.02%)
Acumen Pharmaceuticals, Inc. (ABOS) Q2 2022 Earnings Call Transcript

ABOS earnings call for the period ending June 30, 2022.

ABOS : 2.88 (-4.95%)

Business Summary

Acumen Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It involved in developing a novel disease for Alzheimer. The company's product pipeline consist ACU193. Acumen Pharmaceuticals Inc. is based in CHARLOTTESVILLE, Va.

See More

Key Turning Points

3rd Resistance Point 3.19
2nd Resistance Point 3.11
1st Resistance Point 3.00
Last Price 2.88
1st Support Level 2.81
2nd Support Level 2.73
3rd Support Level 2.62

See More

52-Week High 5.09
Fibonacci 61.8% 3.84
Fibonacci 50% 3.45
Fibonacci 38.2% 3.06
Last Price 2.88
52-Week Low 1.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar